Cleveland Clinic-Led Trial Shows that Cholesterol-Lowering Drug Reduces Heart-Related Events, Including Death, in Statin-Intolerant Patients with Elevated Cardiovascular Risk

Patients had risk factors but no pre-existing heart disease

Read the full article here

Related Articles